Welcome to ‘’16th World Congress on Bioavailability & Bioequivalence” which will be held during March 25-26, 2020 at Miami, USA. We invite all the researchers, delegate, students and healthcare professional to exchange ideas, knowledge at this global conference. This conference is based on the theme “BABE: Essential Innovation in Public and Medical Health”.
BABE 2020 provides a dynamic and energetic platform for understanding the spectrum of drug development and application in drug discovery, clinical trials, pharmacokinetics and pharmacology. A crucial component of abbreviated new drug application (ANDAs), leading to market access of safe, effective, and low cost in the advance studies of bioequivalence.
BABE 2020 Focus on all the Researchers, Principal Investigators, Experts working under academia and healthcare Industry, Business Delegates, Scientists and students across the Globe to provide an International forum for the dissemination of original research results, new Ideas and practical development Experiences.
Session 1: Drug Discovery
In pharmacology field, drug discovery is the process by which new candidate medication are discovered. modern drug discovery involves the identification of screening hits, medicinal chemistry and optimization those hits to increase the affinity, metabolic stability and oral bioavailability. The most important part of drug style involves the identification of characteristic diagnostic biomarkers like a macromolecule to blame for the malady or disorder and so developing a drug molecule of therapeutic efficiency that targets at it. Drug style depends on the data of the three-dimensional structure of building block targets. Drug metabolism is the term which is describe the biotransformation of pharmaceutical substances in the body so that they can be eliminated more easily.
For registration click here.